How osteogenic is dexamethasone?—effect of the corticosteroid on the osteogenesis, extracellular matrix, and secretion of osteoclastogenic factors of jaw periosteum-derived mesenchymal stem/stromal cells
Dexamethasone (dexa) is commonly used to stimulate osteogenic differentiation of mesenchymal stem/stromal cells (MSCs) in vitro. However, it is paradoxical that glucocorticoids (GCs) such as dexa lead to bone loss and increased fracture risk in patients undergoing glucocorticoid therapy, causing glu...
Main Authors: | Felix Umrath, Achim Pfeifer, Wanjing Cen, Marina Danalache, Siegmar Reinert, Dorothea Alexander, Andreas Naros |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.953516/full |
Similar Items
-
Secretomes derived from osteogenically differentiated jaw periosteal cells inhibit phenotypic and functional maturation of CD14+ monocyte-derived dendritic cells
by: Wanjing Cen, et al.
Published: (2023-01-01) -
Impact of Fluid Dynamics on the Viability and Differentiation Capacity of 3D-Cultured Jaw Periosteal Cells
by: Wanjing Cen, et al.
Published: (2022-04-01) -
Jaw Periosteum-Derived Mesenchymal Stem Cells Regulate THP-1-Derived Macrophage Polarization
by: Fang He, et al.
Published: (2021-04-01) -
Zinc Sulfate Stimulates Osteogenic Phenotypes in Periosteum-Derived Cells and Co-Cultures of Periosteum-Derived Cells and THP-1 Cells
by: Jin-Ho Park, et al.
Published: (2021-04-01) -
Characterization and potential of periosteum-derived cells: an overview
by: Rongkai Cao, et al.
Published: (2023-07-01)